Following the CDC’s major revisions to the US childhood immunization schedule, Noel T. Brewer, PhD, distinguished professor ...

Food insecurity was defined as any house that had 3 or more food-insecure conditions. Households that had a household income lower than 185% of the federal poverty line were considered to be ...

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

Medicaid expansion correlates with lower breast cancer mortality, yet non-Hispanic Black women and lowest-income neighborhoods show limited or adverse gains without structural access interventions.

The Go for Bold initiative, which aims to help individuals in Washington County, Maryland, lose 1 million lb by 2030, serves as a successful, replicable model for community-wide health improvement. In ...

The Go for Bold initiative, which aims to help individuals in Washington County, Maryland, lose 1 million lb by 2030, serves as a successful, replicable model for community-wide health improvement.

This episode, titled Rethinking KDIGO Guidance and Payer Models in the Era of Targeted IgA Nephropathy Therapies, features expert nephrologists discussing the following critical questions: What ...

In the final episode, Near-Term Priorities for Transforming Clinical Practice in IgA Nephropathy, the panelist explored the following critical question: What do you hope to see in the next 1–2 years ...

Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum treatment drop-off. Drawing on global data, Toska examined HIV incidence ...

In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first line of therapy did not improve overall survival (OS) compared with reserving ...

Coverage denials and prior authorization delays can compromise timely treatment, creating clinical deterioration and compounding financial toxicity as care escalates. Broadened semaglutide eligibility ...

Experts unpacked MFN drug pricing, expired ACA subsidies, and IRA fallout for community oncology in a recent webinar. The panelists were Lindsay Bealor Greenleaf, JD, MBA, head of market access policy ...